Tests an elemental diet as added treatment for inflammatory bowel disease flares
Tests a liquid elemental diet alongside usual care in adults with inflammatory bowel disease flares.
Key facts
- Who runs it
- Wake Forest University Health Sciences
- Where
- Winston-Salem, United StatesSee the site
- Trial code
- Registry title
- The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares
- Status
- Not yet recruiting
- People taking part
- 42 people, planned
- Starts
- Dec 2026
- Expected to end
- Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- elemental diet (ED)
- Record updated
- 28 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with ulcerative colitis or Crohn's disease who are being treated as outpatients for a flare of their disease.
- Age
- 21 years or older
- Sex
- All sexes can join.
- Disease stage
- A flare of ulcerative colitis or Crohn's disease: a clear increase in symptoms such as belly pain, diarrhea, bleeding or fever. The person is treated as an outpatient.
Main reasons for not taking part
- Needs to be admitted to hospital for the flare
- Allergy to any ingredient in the mBIOTA Elemental Diet
- Pregnant
- Diabetes treated with insulin
- Other medical conditions or personal preferences that would make it hard to follow the elemental diet
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- adults with an established diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease) who are being treated in the outpatient setting for an Inflammatory bowel disease (IBD) flare, defined as a clinically significant increase in IBD symptoms (e.g., abdominal pain, nausea, vomiting, diarrhea, joint pain, fever, bleeding, unintended weight loss)
Who cannot take part
- Patients with allergies to any ingredients in the mBIOTA Elemental Diet
- Patients with diabetes who are taking insulin as part of their treatment plan
- Patients with other medical conditions or personal preferences that would compromise their ability to adhere to the elemental study
- Patients requiring admission to the hospital for treatment of a flare
- Female patients who are pregnant
Where in United States
- Wake Forest University Health SciencesWinston-Salem, United StatesContact: Bradley Joseph, MDNot yet recruiting
About the trial
What the trial wants to find out
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract that affect millions of people in the United States of America. Among patients with IBD, symptomatic flares are quite common; up to 40-50% of patients in some populations report having a flare at least once per month. For most patients with IBD flares, the typical outpatient treatment consists of corticosteroids and, in some instances, initiation of or switching between 5-aminosalicylic acid-acid preparations, immunomodulators, or biologics. These treatments, while often effective, can have harmful side effects, especially when used for long durations of time. Therefore, alternative treatments are highly sought after by both patients and providers.
The 2 groups in the trial
- elemental diet (ED)Treatment being tested
The intervention in this study will be an elemental diet (ED) formulation produced by mBIOTA. All patients randomized to the ED arm will receive a two-week supply (84 servings + additional packets as needed) of the "original" flavor mBIOTA elemental diet.
- control groupNo study treatment, for comparison
Patients randomized to the control group will undergo counseling with a registered dietician for general dietary advice but will be instructed to continue their usual diet, as tolerated, without any restrictions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Elemental Diet as an Adjunctive Therapy for Inflammatory Bowel Disease Flares The EDICT Trial
- Plain-language title
- Tests an elemental diet as added treatment for inflammatory bowel disease flaresGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 September 2026